Comparing neck observation and elective neck dissection for early-stage oral cancer
Official title: Neck Observation Versus Selective Neck Dissection in Patients With cT1N0M0 Oral Squamous Cell Carcinoma: A Multicenter Randomized Controlled Trial
Run by Huashan Hospital · NCT06623266 · Data updated 2026-11-12
This study is testing whether watching the neck or doing surgery to remove lymph nodes is better for people with early-stage oral cancer in terms of survival and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Huashan Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | September 26, 2024 |
| Main results expected | September 30, 2028 |
| Study ends | September 30, 2030 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT06623266 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with cT1N0M0 oral squamous cell carcinoma located in specific oral sites such as the tongue, gingiva, or floor of the mouth.
✕Probably not a fit
Patients with multiple lesions, previous neck dissection, or a history of head and neck radiotherapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the outcomes of two different approaches for managing the neck in patients with early-stage oral squamous cell carcinoma (OSCC). Participants will undergo surgical resection of the primary tumor, with one group receiving elective neck dissection and the other group receiving neck observation. The study aims to assess the rates of lymph node metastasis, disease-free survival, overall survival, and quality of life over a two-year period. A total of 300 patients will be recruited for this trial, with equal distribution between the two treatment arms.
Why it matters
Potential benefit: If successful, this study could help determine the most effective neck management strategy for patients with early-stage oral cancer, potentially reducing unnecessary surgeries and improving quality of life.
How similar studies have gone: Previous studies have suggested that elective neck dissection may not improve survival in similar patient populations, indicating that this trial could provide valuable insights into neck management strategies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Tumor site: tongue, gingiva, buccal mucosa, floor of mouth, hard palate, retromolar eara * Clinical stage is cT1N0M0 (AJCC 8th edition) * Pathological diagnosis of squamous cell carcinoma * Sign the informed consent form Exclusion Criteria: * More than 2 lesions found in the oral cavity * Known history of malignant tumor within five years (unless the patient has undergone curative treatment and there is no disease recurrence within 5 years since the start of treatment) * History of unilateral or bilateral neck dissection in the past * History of previous head and neck radiotherapy * Pregnant or lactating women * Severe, uncontrolled infection or known HIV infection; or previous organ transplantation, stem cell or bone marrow transplantation * Participated in other clinical studies within 30 days before enrollment * Other circumstances that the researcher considers unsuitable for participation in the study
Where it's running
-
Huashan Hospital, Fudan University
Shanghai, China Recruiting
Study contacts
- Principal investigator: Lai-ping Zhong, MD, PhD — Huashan Hospital
- Study coordinator: Lai-ping Zhong, MD, PhD
- Email: zhonglp@hotmail.com
- Phone: +862152888915
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intratumoral fluorescent nivolumab before surgery in head and neck cancer
This study tests injecting fluorescently labeled nivolumab directly into head and neck tumors to see if it is safe and whether it reaches nearby lymph nodes before surgical removal.
-
AI-assisted prehabilitation to help oral cancer patients return to work
This trial will test an AI-assisted prehabilitation program to help adults with oral cancer reduce physical and emotional problems and return to work.
-
AI tool to measure jaw, neck, and shoulder movement for oral cancer care
This project tests an AI system that automatically measures jaw, neck, and shoulder movement for people with or recovering from oral cancer and compares its readings to manual measurements.
-
Dezocine versus nalbuphine with sufentanil for pain control after oral cancer surgery with free-flap reconstruction
This will see if adding dezocine or nalbuphine to sufentanil reduces pain and complications for adults undergoing oral cancer surgery with free-flap reconstruction.
-
Irreversible electroporation to treat recurrent or metastatic neck lymph nodes from thyroid cancer
This will try ultrasound-guided irreversible electroporation (IRE) to destroy recurrent or metastatic cervical lymph nodes in adults with thyroid cancer who have already had thyroid surgery and neck dissection.
-
Hydrogen water oral care after free flap reconstruction for oral cancer
A randomized trial tests whether hydrogen water oral care helps reduce inflammation and pain and improve oral bacteria after surgery for oral cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.